Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0000947871-18-000423

Director sold 10,300 shares at $13.50 ($139,050)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Peter A. Director 2018-05-14 Sale −10,300 $13.50 $139,050 5,091,010 I: show line 1 in the form
Open-market sales · 10,300 sh · avg $13.50 · $139,050
Loading xslF345X03/ss92648_4.xml…